NO20081622L - Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser - Google Patents

Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser

Info

Publication number: NO20081622L
Authority: NO; Norway
Prior art keywords: methods; cell culture; producing proteins; antigenesis; compound
Prior art date: 2005-10-24

Application number

NO20081622A

Other languages

English (en)

Norwegian (no)

Inventor

Denis Drapeau

Wenge Wang

Yen-Tung Luan

Paul Thoday

Judy Chou

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-24

Filing date

2008-04-02

Publication date

2008-06-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37873105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081622(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-04-02 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-06-18 Publication of NO20081622L publication Critical patent/NO20081622L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Pyridine Compounds (AREA)

NO20081622A 2005-10-24 2008-04-02 Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser NO20081622L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72957305P	2005-10-24	2005-10-24
PCT/US2006/041256 WO2007050498A2 (fr)	2005-10-24	2006-10-24	Procedes de production de proteines utilisant des composes anti-senescence

Publications (1)

Publication Number	Publication Date
NO20081622L true NO20081622L (no)	2008-06-18

Family

ID=37873105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081622A NO20081622L (no)	2005-10-24	2008-04-02	Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser

Country Status (23)

Country	Link
US (1)	US20070110743A1 (fr)
EP (1)	EP1941026B1 (fr)
JP (2)	JP2009512459A (fr)
KR (1)	KR101402634B1 (fr)
CN (1)	CN101297027B (fr)
AR (1)	AR058140A1 (fr)
AU (1)	AU2006306433B2 (fr)
BR (1)	BRPI0617744A2 (fr)
CA (1)	CA2627003C (fr)
CR (1)	CR9897A (fr)
DK (1)	DK1941026T3 (fr)
EC (1)	ECSP088395A (fr)
ES (1)	ES2485374T3 (fr)
IL (1)	IL190550A (fr)
NI (1)	NI200800111A (fr)
NO (1)	NO20081622L (fr)
PE (1)	PE20070796A1 (fr)
PL (1)	PL1941026T3 (fr)
PT (1)	PT1941026E (fr)
RU (1)	RU2491347C2 (fr)
SI (1)	SI1941026T1 (fr)
TW (1)	TW200736397A (fr)
WO (1)	WO2007050498A2 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101541950A (zh)	2006-07-13	2009-09-23	惠氏公司	糖蛋白的产生
MX345141B (es)	2006-09-13	2017-01-18	Abbvie Inc *	Mejoras de cultivos celulares.
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
TW200902708A (en) *	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
NZ592095A (en) *	2008-10-20	2013-01-25	Abbott Lab	Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
EP2346897A2 (fr)	2008-10-20	2011-07-27	Abbott Laboratories	Inactivation virale pendant la purification d'anticorps
US8859235B2 (en)	2009-08-14	2014-10-14	Basf Se	Methods in cell cultures, and related inventions, employing certain additives
CN103080300B (zh)	2010-08-05	2015-11-25	安姆根有限公司	增加细胞培养物的产率和活力的二肽
US20130224855A1 (en) *	2010-08-31	2013-08-29	Abhishek Gupta	Culture medium for eukaryotic cells
US9062106B2 (en)	2011-04-27	2015-06-23	Abbvie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
TW201247874A (en) *	2011-05-25	2012-12-01	United Biomedical Inc	Method for producing the activity of bone activating protein
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
WO2013158273A1 (fr)	2012-04-20	2013-10-24	Abbvie Inc.	Procédés de modulation de la distribution de variant de lysine c-terminal
US9334319B2 (en)	2012-04-20	2016-05-10	Abbvie Inc.	Low acidic species compositions
US9249182B2 (en)	2012-05-24	2016-02-02	Abbvie, Inc.	Purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
BR112015004467A2 (pt)	2012-09-02	2017-03-21	Abbvie Inc	método para controlar a heterogeneidade de proteínas
AU2013381687A1 (en)	2013-03-12	2015-09-24	Abbvie Inc.	Human antibodies that bind human TNF-alpha and methods of preparing the same
JP6326601B2 (ja) *	2013-03-13	2018-05-23	アンティースソシエテアノニム	皮膚更新のためのペプチド及び前記ペプチドを使用する方法
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en)	2013-03-14	2016-11-22	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
WO2014159579A1 (fr)	2013-03-14	2014-10-02	Abbvie Inc.	Anticorps anti-tnfα ayant mutés et leurs procédés d'utilisation
KR20210037745A (ko)	2013-03-15	2021-04-06	제넨테크, 인크.	항산화제를 함유하는 세포 배양 조성물 및 폴리펩티드 생산 방법
US9598667B2 (en)	2013-10-04	2017-03-21	Abbvie Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
CN106170298B (zh)	2013-10-16	2024-01-09	前瞻疗法公司	用于提高抗体稳定性的缓冲液制剂
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
CN104398398A (zh) *	2014-10-27	2015-03-11	陈少威	一种细胞量子动力素(平衡剂)及其使用方法
MA40864A (fr) *	2014-10-31	2017-09-05	Biogen Ma Inc	Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères
WO2016118707A1 (fr)	2015-01-21	2016-07-28	Oncobiologics, Inc.	Modulation de variants de charge dans une composition d'anticorps monoclonaux
TW202440903A (zh)	2015-08-04	2024-10-16	美商再生元醫藥公司	補充牛磺酸之細胞培養基及用法（一）
JP2018536404A (ja)	2015-11-09	2018-12-13	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｃｈｏ細胞において産生したポリペプチドの品質特性を操作する方法
WO2017120359A1 (fr) *	2016-01-06	2017-07-13	Oncobiologics, Inc.	Réduction des espèces de masse moléculaire élevée, des espèces de charge acide, et des fragments dans une composition d'anticorps monoclonaux
CN109563161A (zh)	2016-02-03	2019-04-02	安口生物公司	用于提高抗体稳定性的缓冲制剂
CN111201434A (zh) *	2017-10-16	2020-05-26	瑞泽恩制药公司	用于控制细胞培养物中的过程变量的原位拉曼光谱系统和方法
US12297451B1 (en)	2019-10-25	2025-05-13	Regeneron Pharmaceuticals, Inc.	Cell culture medium
WO2025053166A1 (fr) *	2023-09-05	2025-03-13	味の素株式会社	Composition de milieu de culture
WO2025142807A1 (fr) *	2023-12-25	2025-07-03	武田薬品工業株式会社	Procédé de culture cellulaire

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8308235D0 (en) *	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US5225539A (en) *	1986-03-27	1993-07-06	Medical Research Council	Recombinant altered antibodies and methods of making altered antibodies
US5223409A (en) *	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
DK0417563T3 (da) *	1989-09-12	2000-11-06	Hoffmann La Roche	TNF-bindende proteiner
US5859205A (en) *	1989-12-21	1999-01-12	Celltech Limited	Humanised antibodies
EP0571390B1 (fr) *	1990-11-23	2000-03-08	Peptech Limited	Retardement, prevention et/ou renversement de la senescence de cellules
CA2103059C (fr) *	1991-06-14	2005-03-22	Paul J. Carter	Methode de production d'anticorps humanises
RU2245365C2 (ru) *	1994-01-03	2005-01-27	Генентек Инк.	Тромбопоэтин
US5830761A (en) *	1995-06-07	1998-11-03	Genetics Institute, Inc.	Medium and methods for culturing mammalian cho cells
RU2134120C1 (ru) *	1995-06-26	1999-08-10	Безруков Михаил Васильевич	Средство для стабилизации пептидной связи в белковом препарате
AU725609C (en) *	1995-08-18	2002-01-03	Morphosys Ag	Protein/(poly)peptide libraries
JP4306813B2 (ja) *	1995-09-19	2009-08-05	アスビオファーマ株式会社	動物細胞の新規培養方法
US6146847A (en) *	1996-11-01	2000-11-14	Genespan Corporation	Stabilized transient gene expression
DE69738539T2 (de) *	1996-12-03	2009-03-26	Amgen Fremont Inc.	Vollkommen humane Antikörper die EGFR binden
US20030040095A1 (en) *	2001-03-16	2003-02-27	Achille Arini	Method for the production of pharmaceutically active recombinant proteins
PL366621A1 (en) *	2001-04-24	2005-02-07	Innogenetics N.V.	Core-glycosylated hcv envelope proteins
US7541164B2 (en) *	2002-12-23	2009-06-02	Bristol-Myers Squibb Company	Mammalian cell culture processes for protein production
KR101321876B1 (ko) *	2003-10-27	2013-10-28	와이어쓰 엘엘씨	하이드록시아파타이트 크로마토그래피를 사용한 고분자량 응집체의 제거
WO2005064013A1 (fr) *	2003-12-23	2005-07-14	Bart Janssen	Utilisation de genes associes au metabolisme de la carnosine pour determiner la predisposition/receptivite a la nephropathie diabetique
US7300773B2 (en) *	2004-08-27	2007-11-27	Wyeth Research Ireland Limited	Production of TNFR-Ig
TWI374935B (en) *	2004-08-27	2012-10-21	Pfizer Ireland Pharmaceuticals	Production of α-abeta
US7294484B2 (en) *	2004-08-27	2007-11-13	Wyeth Research Ireland Limited	Production of polypeptides
US7426440B2 (en) *	2004-09-24	2008-09-16	Nutritional Bioscience Ltd.	Repair and protection factor scoring method for bioactive agents

2006
- 2006-10-23 AR ARP060104624A patent/AR058140A1/es unknown
- 2006-10-23 PE PE2006001284A patent/PE20070796A1/es not_active Application Discontinuation
- 2006-10-24 KR KR1020087009856A patent/KR101402634B1/ko not_active Expired - Fee Related
- 2006-10-24 WO PCT/US2006/041256 patent/WO2007050498A2/fr not_active Ceased
- 2006-10-24 DK DK06844211.0T patent/DK1941026T3/da active
- 2006-10-24 SI SI200631796T patent/SI1941026T1/sl unknown
- 2006-10-24 US US11/585,607 patent/US20070110743A1/en not_active Abandoned
- 2006-10-24 AU AU2006306433A patent/AU2006306433B2/en not_active Ceased
- 2006-10-24 RU RU2008113220/10A patent/RU2491347C2/ru active
- 2006-10-24 CN CN2006800396267A patent/CN101297027B/zh not_active Expired - Fee Related
- 2006-10-24 PT PT68442110T patent/PT1941026E/pt unknown
- 2006-10-24 CA CA2627003A patent/CA2627003C/fr active Active
- 2006-10-24 PL PL06844211T patent/PL1941026T3/pl unknown
- 2006-10-24 EP EP06844211.0A patent/EP1941026B1/fr active Active
- 2006-10-24 ES ES06844211.0T patent/ES2485374T3/es active Active
- 2006-10-24 TW TW095139179A patent/TW200736397A/zh unknown
- 2006-10-24 BR BRPI0617744-1A patent/BRPI0617744A2/pt not_active Application Discontinuation
- 2006-10-24 JP JP2008537834A patent/JP2009512459A/ja not_active Withdrawn
2008
- 2008-04-01 IL IL190550A patent/IL190550A/en active IP Right Grant
- 2008-04-02 NO NO20081622A patent/NO20081622L/no not_active Application Discontinuation
- 2008-04-09 NI NI200800111A patent/NI200800111A/es unknown
- 2008-04-18 CR CR9897A patent/CR9897A/es not_active Application Discontinuation
- 2008-04-23 EC EC2008008395A patent/ECSP088395A/es unknown
2013
- 2013-04-26 JP JP2013094315A patent/JP5907928B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR101402634B1 (ko)	2014-06-03
NI200800111A (es)	2009-03-03
DK1941026T3 (da)	2014-07-21
ECSP088395A (es)	2008-05-30
TW200736397A (en)	2007-10-01
AR058140A1 (es)	2008-01-23
PL1941026T3 (pl)	2014-12-31
PT1941026E (pt)	2014-07-31
CN101297027B (zh)	2013-04-03
WO2007050498A3 (fr)	2007-07-12
EP1941026B1 (fr)	2014-06-04
CR9897A (es)	2008-07-29
HK1120552A1 (en)	2009-04-03
JP5907928B2 (ja)	2016-04-26
JP2009512459A (ja)	2009-03-26
US20070110743A1 (en)	2007-05-17
BRPI0617744A2 (pt)	2011-08-02
JP2013165728A (ja)	2013-08-29
IL190550A0 (en)	2008-11-03
WO2007050498A2 (fr)	2007-05-03
IL190550A (en)	2017-01-31
CN101297027A (zh)	2008-10-29
AU2006306433A1 (en)	2007-05-03
CA2627003C (fr)	2018-08-28
ES2485374T3 (es)	2014-08-13
AU2006306433B2 (en)	2013-04-18
KR20080063365A (ko)	2008-07-03
SI1941026T1 (sl)	2014-07-31
CA2627003A1 (fr)	2007-05-03
RU2008113220A (ru)	2009-12-10
RU2491347C2 (ru)	2013-08-27
EP1941026A2 (fr)	2008-07-09
PE20070796A1 (es)	2007-08-15

Publication	Publication Date	Title
NO20081622L (no)	2008-06-18	Fremgangsmater for produksjon av proteiner ved anvendelse av anti-senescence forbindelser
MX2009011363A (es)	2009-11-05	Metodo de produccion de proteinas utilizando compuestos anti-senectud.
DK1623023T3 (da)	2009-03-02	Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra
EA200870204A1 (ru)	2009-04-28	Системы и способы производства биотоплива и связанных с этим материалов
EA201270224A1 (ru)	2012-09-28	Среда для культивирования клеток для экспрессии белков adamts
MX2007003906A (es)	2007-05-21	Metodos y composiciones para mejorar la produccion de proteinas recombinantes.
WO2008060541A3 (fr)	2008-08-28	Expansion in vitro de cellules post-natales au moyen de microporteurs
NO20072719L (no)	2007-05-29	Serumfritt cellekulturmedium for pattedyrceller
BRPI0513837A (pt)	2008-05-20	células hospedeiras geneticamente modificadas e uso das mesmas para produzir compostos isoprenóides
SG149061A1 (en)	2009-01-29	Definitive endoderm
EP4368701A3 (fr)	2024-09-04	Système de culture sans dispositif d'alimentation
NO20071619L (no)	2007-04-25	Fremgangsmate for fremstilling av indazol forbindelse
WO2004090096A3 (fr)	2005-03-03	Procedes de differenciation neuronale de cellules souches embryonnaires au moyen de techniques de passage de protease
AU2019268061A1 (en)	2019-12-12	Placental stem cell populations
TW200720232A (en)	2007-06-01	Crystalline solid forms of tigecycline and methods of preparing same
BR0313559A (pt)	2005-07-12	Método para o cultivo de células primárias e para a amplificação de vìrus sob condições isentas de soro
WO2010020876A3 (fr)	2010-04-15	Procédé de culture cellulaire
DE60307615D1 (de)	2006-09-28	Zellkulturmedium
NO20061470L (no)	2006-05-12	Fremgangsmate for fremstilling av gamma-karboksylerte proteiner
EA201170025A1 (ru)	2011-08-30	Способы повышения жизнеспособности и продукции культуры клеток
CY1112746T1 (el)	2016-02-10	Κρυοσυντηρηση ηπατοκυτταρων
WO2007016366A3 (fr)	2009-04-30	Conditions definies de culture de cellules souches embryonnaires humaines
MX2009007790A (es)	2009-07-31	Mejora del crecimiento celular.
MY198223A (en)	2023-08-14	Cell Culture Medium For Eukaryotic Cells
NO20065101L (no)	2006-11-06	Forbindelse WS727713

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application